Published Date: 31-Jan-2020
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Asia Pacific Retinal Imaging Devices Market, published by KBV Research, the Asia Pacific Retinal Imaging Devices Market would witness market growth of 7.1% CAGR during the forecast period (2019-2025).
The China market dominated the Asia Pacific OCT Market by Country in 2018, and would continue to be a dominant market till 2025. The India market is exhibiting a CAGR of 9% during (2019 - 2025). Additionally, The Australia market would witness a CAGR of 8.8% during (2019 - 2025).
The Hospitals market dominated the Japan Retinal Imaging Market by End-Use in 2018, thereby, achieving a market value of $116.3 Million by 2025, growing at a CAGR of 7.9 % during the forecast period. The ASC’s market is poised to grow at a CAGR of 8.3% during (2019 - 2025).
The Fundus Camera market dominated the South Korea Retinal Imaging Market by Type in 2018, growing at a CAGR of 7.5 % during the forecast period. The Fluorescein Angiography market is anticipated to witness a CAGR of 7.9% during (2019 - 2025).
Structural Insights: https://www.kbvresearch.com/asia-pacific-retinal-imaging-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Topcon Corporation, Carl Zeiss AG, Olympus Corporation, Robert Bosch GmbH (Bosch Healthcare), Revenio Group Oyj (CenterVue SpA), Nikon Corporation (Optos PLC), Optomed PLC, Epipole Ltd., Nidek Co., Ltd., and Eyenuk, Inc.
By End Use
Unique Offerings from KBV Research